EA201691682A1 - Способы анализирования редких циркулирующих в крови клеток - Google Patents

Способы анализирования редких циркулирующих в крови клеток

Info

Publication number
EA201691682A1
EA201691682A1 EA201691682A EA201691682A EA201691682A1 EA 201691682 A1 EA201691682 A1 EA 201691682A1 EA 201691682 A EA201691682 A EA 201691682A EA 201691682 A EA201691682 A EA 201691682A EA 201691682 A1 EA201691682 A1 EA 201691682A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
circulating cells
blood
rare circulating
analyzing rare
Prior art date
Application number
EA201691682A
Other languages
English (en)
Inventor
Дена Марринуччи
Original Assignee
Эпик Сайенсиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эпик Сайенсиз, Инк. filed Critical Эпик Сайенсиз, Инк.
Publication of EA201691682A1 publication Critical patent/EA201691682A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589—CD45

Abstract

Данное раскрытие предоставляет способы анализирования редких циркулирующих клеток (РЦК) на клеточном и молекулярном уровне после их определения в необогащенных образцах крови, и способы данного раскрытия выступают в роли диагностических методов для нескольких заболеваний, включая заболевания сердечно-сосудистой системы и рак.
EA201691682A 2014-02-21 2015-02-19 Способы анализирования редких циркулирующих в крови клеток EA201691682A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461943192P 2014-02-21 2014-02-21
PCT/US2015/016499 WO2015127008A1 (en) 2014-02-21 2015-02-19 Methods for analyzing rare circulating cells

Publications (1)

Publication Number Publication Date
EA201691682A1 true EA201691682A1 (ru) 2017-02-28

Family

ID=53878933

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691682A EA201691682A1 (ru) 2014-02-21 2015-02-19 Способы анализирования редких циркулирующих в крови клеток

Country Status (4)

Country Link
US (2) US10545151B2 (ru)
EP (1) EP3108246B1 (ru)
EA (1) EA201691682A1 (ru)
WO (1) WO2015127008A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115060882A (zh) 2009-10-21 2022-09-16 斯克里普斯研究所 用非稀有细胞检测稀有细胞的方法
EA201691496A1 (ru) 2014-01-27 2016-12-30 Эпик Сайенсиз, Инк. Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток
WO2015127008A1 (en) 2014-02-21 2015-08-27 Epic Sciences, Inc. Methods for analyzing rare circulating cells
KR101996218B1 (ko) * 2017-09-05 2019-10-01 주식회사 싸이토젠 Axl 기반 암환자 스크리닝 방법
CN108776230A (zh) * 2018-08-10 2018-11-09 北京莱尔生物医药科技有限公司 一种检测er、pr抗原的免疫荧光试剂盒及应用
CN111321120B (zh) * 2020-04-10 2022-05-06 西安交通大学医学院第二附属医院 小鼠肾透明细胞癌循环肿瘤细胞系和人源性肾透明细胞癌循环肿瘤细胞的分离与培养方法
US20230175073A1 (en) * 2021-12-07 2023-06-08 Epic Sciences, Inc. Enhanced characterization of breast cancer
CN114441411B (zh) * 2021-12-31 2023-12-19 江苏汇先医药技术有限公司 一种肿瘤细胞捕获芯片的捕获结果判读方法及***

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830721A1 (de) 1988-09-09 1990-03-22 Michael Dr Menton In labors, insbesondere in medizinischen labors, zu verwendender objekttraeger
AU9233698A (en) 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6197523B1 (en) * 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US6670197B2 (en) 1997-11-24 2003-12-30 David L. Rimm Method for assaying whole blood for the presence or absence of circulating cancer or other target cell fragments
US20010018058A1 (en) 1997-12-24 2001-08-30 Reed Steven G. Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
US8192994B2 (en) 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
EP1062515B1 (en) 1998-02-12 2009-11-25 Immunivest Corporation Methods and reagents for the rapid and efficient isolation of circulating cancer cells
AU754722B2 (en) 1998-05-09 2002-11-21 Ikonisys Inc. Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis
US6960449B2 (en) 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
US7546210B2 (en) 2000-06-08 2009-06-09 The Regents Of The University Of California Visual-servoing optical microscopy
US7033832B2 (en) 2000-10-13 2006-04-25 University Of Medicine And Dentistry Of New Jersey Endothelial cell—cell cohesion
AU2001297830A1 (en) 2000-10-25 2002-12-09 Exiqon A/S Closed substrate platforms suitable for analysis of biomolecules
WO2002089657A2 (en) 2001-05-04 2002-11-14 Biosite, Inc. Diagnostic markers of acute coronary syndromes and methods of use thereof
US20080009019A1 (en) 2001-06-13 2008-01-10 Smithkline Beecham Corporation High throughput method for screening candidate compounds for biological activity
CN1571634A (zh) 2001-08-23 2005-01-26 免疫公司 用于分析的细胞和生物学标本的稳定
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
US7943093B2 (en) 2001-12-12 2011-05-17 Erie Scientific Company Cover slip
EP1474772A4 (en) 2002-02-14 2005-11-09 Immunivest Corp METHOD AND ALGORITHMS FOR CELL DETERMINATION IN A COST-EFFECTIVE CYTOMETER
US7113624B2 (en) 2002-10-15 2006-09-26 Palo Alto Research Center Incorporated Imaging apparatus and method employing a large linear aperture
US7305112B2 (en) 2002-10-15 2007-12-04 The Scripps Research Institute Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media
US7282180B2 (en) 2003-07-02 2007-10-16 Immunivest Corporation Devices and methods to image objects
US7372985B2 (en) 2003-08-15 2008-05-13 Massachusetts Institute Of Technology Systems and methods for volumetric tissue scanning microscopy
US8603763B2 (en) 2004-04-08 2013-12-10 Cornell Research Foundation, Inc. Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
WO2006041453A1 (en) 2004-09-30 2006-04-20 Immunivest Corporation Circulating tumor cells (ctc’s): apoptotic assessment in prostate cancer patients
JP5058815B2 (ja) 2004-11-24 2012-10-24 バッテル メモリアル インスティチュート 細胞撮像用の光学システム
US7280261B2 (en) 2004-12-20 2007-10-09 Palo Alto Research Center Incorporated Method of scanning and light collection for a rare cell detector
US20090081688A1 (en) 2005-06-20 2009-03-26 Advanced Cell Diagnostics Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
US20070009389A1 (en) 2005-07-08 2007-01-11 Antti Seppo Slide deposition chamber
US9134237B2 (en) * 2005-09-20 2015-09-15 Janssen Diagnotics, LLC High sensitivity multiparameter method for rare event analysis in a biological sample
US20090317836A1 (en) * 2006-01-30 2009-12-24 The Scripps Research Institute Methods for Detection of Circulating Tumor Cells and Methods of Diagnosis of Cancer in Mammalian Subject
US8337755B2 (en) 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
US20080076727A1 (en) 2006-03-29 2008-03-27 John Wayne Cancer Institute Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
WO2007131507A2 (en) 2006-05-13 2007-11-22 Dako Denmark A/S Methods for flow cytometry analyses of cells without lysing subpopulations
NZ573187A (en) 2006-06-02 2011-11-25 Pfizer Prod Inc Circulating tumor cell assay for predicting efficacy of 1gf-1r antagonist therapy
WO2008111990A1 (en) 2006-06-14 2008-09-18 Cellpoint Diagnostics, Inc. Rare cell analysis using sample splitting and dna tags
WO2008014516A2 (en) 2006-07-28 2008-01-31 Living Microsystems, Inc. Selection of cells using biomarkers
CN101606060A (zh) 2006-09-05 2009-12-16 维里德克斯有限责任公司 细胞图像的归类方法
US8244021B2 (en) 2006-12-20 2012-08-14 Ventana Medical Systems, Inc. Quantitative, multispectral image analysis of tissue specimens stained with quantum dots
CN101226118B (zh) 2007-01-19 2010-06-16 中国医学科学院肿瘤研究所 一种兼容免疫荧光分析的细胞化学染色方法及其用途
EP2155856A4 (en) 2007-06-05 2013-06-26 Nanopoint Inc SYSTEMS AND METHODS OF CELL TRAY
US8889361B2 (en) 2007-09-19 2014-11-18 The Research Foundation For The State University Of New York Gene expression signatures in enriched tumor cell samples
WO2009051734A1 (en) 2007-10-17 2009-04-23 The General Hospital Corporation Microchip-based devices for capturing circulating tumor cells and methods of their use
WO2009064933A2 (en) 2007-11-13 2009-05-22 Ikonisys, Inc. Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescence microscope
US20090258365A1 (en) * 2008-03-25 2009-10-15 Terstappen Leon W M M METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
US20110189670A1 (en) 2008-07-07 2011-08-04 Ruth L Katz Circulating Tumor and Tumor Stem Cell Detection Using Genomic Specific Probes
US9779213B2 (en) 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US8324280B2 (en) 2008-08-07 2012-12-04 The University Of British Columbia Treatment of prostate cancer with DDC inhibitor
CA2736178A1 (en) 2008-09-05 2010-03-11 Peter Kuhn Methods for the detection of circulating tumor cells
CN115060882A (zh) 2009-10-21 2022-09-16 斯克里普斯研究所 用非稀有细胞检测稀有细胞的方法
CA2788245A1 (en) 2010-01-27 2011-08-04 Duke University Biomarkers for circulating tumor cells
EP2545186A1 (en) 2010-03-08 2013-01-16 Regents Of The University Of Minnesota Androgen receptor isoforms and methods
TWI539158B (zh) 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
WO2012048113A2 (en) 2010-10-07 2012-04-12 The General Hospital Corporation Biomarkers of cancer
EP3564395A1 (en) 2010-12-30 2019-11-06 Foundation Medicine, Inc. Optimization of multigene analysis of tumor samples
WO2012103025A2 (en) 2011-01-24 2012-08-02 Epic Sciences, Inc. Methods for obtaining single cells and applications of single cell omics
CA2840226A1 (en) 2011-07-07 2013-01-10 Scripps Health Method of analyzing cardiovascular disorders and uses thereof
US20130078667A1 (en) 2011-09-22 2013-03-28 Oscar B. Goodman Methods for detecting and collecting circulating tumor cells
WO2013049926A1 (en) 2011-10-06 2013-04-11 UNIVERSITé LAVAL PROGNOSTIC MARKERS OF INHERITED VARIATIONS IN THE 17β-HYDROXYSTEROID DEHYDROGENASE (HSD17B) GENES FOR PROSTATE CANCER
JP2015505966A (ja) 2011-12-09 2015-02-26 ザ スクリップス リサーチ インスティテュート 循環腫瘍細胞を特定するための装置、システム、及び方法
EP2798355B1 (en) 2011-12-30 2018-09-12 Ventana Medical Systems, Inc. Automated analysis of circulating tumor cells
EP2807485B1 (en) * 2012-01-24 2019-03-13 Pfizer Inc Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject
WO2013181532A1 (en) 2012-06-01 2013-12-05 Creatv Microtech, Inc. Capture, identification and use of a new biomarker of solid tumors in body fluids
WO2014008155A1 (en) 2012-07-02 2014-01-09 The General Hospital Corporation Diagnosis and monitoring treatment of prostate cancer
US20140024024A1 (en) * 2012-07-17 2014-01-23 General Electric Company Methods of detecting dna, rna and protein in biological samples
US9671405B2 (en) 2012-09-19 2017-06-06 Cornell University Identifying taxane sensitivity in prostate cancer patients
EP2912194B1 (en) 2012-10-26 2019-05-08 Memorial Sloan-Kettering Cancer Center Androgen receptor variants and methods for making and using
US10161939B2 (en) 2013-02-02 2018-12-25 Duke University Method of isolating circulating tumor cells
PL2972373T3 (pl) 2013-03-15 2020-03-31 F. Hoffmann-La Roche Ag Biomarkery i sposoby leczenia stanów związanych z PD-1 i PD-L1
EP3693475A1 (en) 2013-04-05 2020-08-12 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
EP3052940B1 (en) 2013-09-30 2021-05-26 The Scripps Research Institute Genotypic and phenotypic analysis of circulating tumor cells to monitor tumor evolution in prostate cancer patients
US20150147339A1 (en) 2013-11-15 2015-05-28 Psma Development Company, Llc Biomarkers for psma targeted therapy for prostate cancer
US20170192003A1 (en) 2013-12-03 2017-07-06 The Scripps Research Institute Compositions and methods for fluid biopsy of melanoma
EP3090264B1 (en) 2013-12-30 2020-02-12 The Scripps Research Institute Circulating tumor cell diagnostics for lung cancer
WO2015112999A1 (en) 2014-01-27 2015-07-30 Epic Sciences, Inc. Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
EA201691496A1 (ru) 2014-01-27 2016-12-30 Эпик Сайенсиз, Инк. Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток
US20160040245A1 (en) 2014-01-27 2016-02-11 Epic Sciences, Inc. Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
ES2868077T3 (es) 2014-01-30 2021-10-21 Epic Sciences Inc Diagnóstico mediante células tumorales circulantes para biomarcadores predictivos de la resistencia a las terapias selectivas del receptor de andrógenos (RA)
WO2015116780A1 (en) 2014-01-31 2015-08-06 Epic Sciences, Inc. Methods for the detection and quantification of circulating tumor cell mimics
WO2015127008A1 (en) 2014-02-21 2015-08-27 Epic Sciences, Inc. Methods for analyzing rare circulating cells
WO2016049291A1 (en) 2014-09-25 2016-03-31 Epic Sciences, Inc. Circulating tumor cell diagnostics for identification of resistance to androgen receptor targeted therapies
US20170242016A1 (en) 2014-10-15 2017-08-24 Epic Sciences, Inc. Circulating tumor cell diagnostics for therapy targeting pd-l1
WO2016196284A1 (en) 2015-05-29 2016-12-08 Epic Sciences, Inc. Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) associated to phenotypic ctc heterogeneity in metastatic castrate resistant prostate cancer (mcrpc)
CA3004150A1 (en) 2015-11-03 2017-05-11 Epic Sciences, Inc. Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity
CA3010311A1 (en) 2016-01-06 2017-07-13 Epic Sciences, Inc. Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity

Also Published As

Publication number Publication date
EP3108246B1 (en) 2019-10-09
EP3108246A4 (en) 2017-09-06
US11340228B2 (en) 2022-05-24
US10545151B2 (en) 2020-01-28
EP3108246A1 (en) 2016-12-28
WO2015127008A1 (en) 2015-08-27
US20200355690A1 (en) 2020-11-12
US20170010268A1 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
EA201691682A1 (ru) Способы анализирования редких циркулирующих в крови клеток
EA201690617A1 (ru) Комбинирование anti-lag-3-антител и анти-pd-1-антител для лечения опухолей
HK1257999A1 (zh) 用於臨床應用的分析物收集、提取、濃縮和檢測的方法和裝置
IL258101A (en) Device and system for testing samples, especially blood, and methods for using them
MX2018010473A (es) Terapia de combinacion con anticuerpos anti cumulo de diferenciacion 73 (cd73).
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
BR112016022814A8 (pt) composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico
BR112015001592A8 (pt) análise de imagem e medidas de amostras biológicas
HK1249553A1 (zh) 在血液樣本中的循環腫瘤細胞的數字分析
EA201691866A1 (ru) Проникающие в опухоль лимфоциты для адоптивной клеточной терапии
MX2018003374A (es) Anticuerpos terapeuticos cd47.
WO2015103293A3 (en) Systems, compositions and methods for detecting and analyzing micro-rna profiles from a biological sample
GB2519906A (en) Methods and systems for detecting biological components
EA201891291A1 (ru) Мультиспецифические антитела
EA201591740A1 (ru) Вирусы болезни ньюкасла и их применение
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
EA201790010A1 (ru) Гамма-дельта t-клетки и их применение
EA201491833A1 (ru) Основанные на клетках перекрестные анализы и их применение
EP3186397C0 (en) USE OF BIOMARKERS OF CIRCULATING CELLS IN THE BLOOD FOR THE DETECTION AND DIAGNOSIS OF DISEASES, AND THEIR ISOLATION PROCESSES
MY187050A (en) Cancer cell-specific antibody, anticancer agent, and cancer testing method
AU2017248682B2 (en) Method for detecting and/or characterising tumour cells and associated apparatus
CY1123698T1 (el) Εμπλουτισμος κυκλοφορουντων κυτταρων ογκου μεσω εξαντλησης λευκων αιμοσφαιριων
WO2015153948A3 (en) Microtentacle imaging in patient tumor samples
IL245766B (en) Different levels in blood cell samples of emt markers for the diagnosis of cancer, in particular colon cancer (crc) and pancreatic cancer (pc)
MX2019007894A (es) Composiciones y metodos para detectar el adn tumoral circulante.